Back to search
FDAFDA · Food and drugs·Recall number D-094-2013

Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.

Published December 26, 2012 · Recall initiated: December 13, 2012

Summary

FDA records drug Class III recall D-094-2013, published December 26, 2012 and initiated December 13, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 63,627 cartons; Lot: 432127A Exp. 01/13, 478076A Exp. 05/13, 515539B Exp.09/13. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Laboratories Inc
Distributor
Nationwide
Lot
432127A Exp. 01/13, 478076A Exp. 05/13, 515539B Exp.09/13
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880. recalled?

Yes. FDA published recall D-094-2013 on December 26, 2012. Reported hazard: Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter